1-3 of 3
Leah Martell
Close
Sort by
Journal Articles

Recombinant ADAMTS13 for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura: Design of a Phase 3b Open-Label Continuation Study of Prophylactic and on-Demand Treatment

Nisha Jain, Cecilia Marquez, Leah Martell
Journal: Blood
Blood (2021) 138 (Supplement 1): 4252.
https://doi.org/10.1182/blood-2021-146148
Published: 2021
Journal Articles

Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Marie Scully, Paul Knöbl, Karim Kentouche, Lawrence Rice, Jerzy Windyga, Reinhard Schneppenheim, Johanna A. Kremer Hovinga, Michiko Kajiwara, Yoshihiro Fujimura, Caterina Maggiore, Jennifer Doralt, Christopher Hibbard, Leah Martell, Bruce Ewenstein
Journal: Blood
Blood (2017) 130 (19): 2055–2063.
https://doi.org/10.1182/blood-2017-06-788026
Published: 2017
Includes: Supplemental data
Journal Articles

Pharmacodynamic Profile of a Recombinant ADAMTS13 (BAX930) in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome (USS))

Marie Scully, Paul Knoebl, MD, Karim Kentouche, Lawrence Rice, MD, Jerzy Windyga, MD, Reinhard Schneppenheim, Johanna A Kremer Hovinga, MD PhD, Michiko Kajiwara, Caterina Maggiore, Jennifer Doralt, Leah Martell, Bruce M. Ewenstein
Journal: Blood
Blood (2016) 128 (22): 135.
https://doi.org/10.1182/blood.V128.22.135.135
Published: 2016